切换导航
关闭
  • 菜单
  • Setting

Apoptosis - Bcl-2 - PDGFR

Apoptosis, also known as programmed cell death, is rigorously controlled process of cell death that leads to phagocytosis of unwanted cell. It is triggered after sufficient cellular damage and activated through extrinsic or intrinsic pathways. The intrinsic pathway is mainly occurs via release of cytochrome c from the mitochondria and regulates mitochondrial outer membrane permeabilization by Bcl-2 family proteins. The extrinsic pathway is induced by ligand binding to death receptor, such as Fas, TNFαR, DR3, DR4, and DR5. Caspases then cleave target proteins and nuclear lamins to promote DNA degradation, resulting apoptotic cells undergo phagocytosis. In addition, p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some Inhibitors of apoptosis proteins (IAPs), such as XIAP/BIRC4 and Bruce/BIRC6, can block casapse activity through direct binding, while other IAPs, such as cIAP1/BIRC2, cIAP2/BIRC3, act as ubiquitin ligases that target caspases for ubiquitin-mediated degradation. Apoptosis is essential for growth, development and aging in multicellular organisms. Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases, including cancer.

12件产品中的 1-10

页面
每页
清除全部
  1. BDA-366
    B5978 BDA-366
    Target: Bcl-2
    Summary: BCL2 BH4 结构域的选择性拮抗剂
      ≥50.4 mg/mL
      insoluble in H2O
  2. Radotinib(IY-5511)
    B5846 Radotinib(IY-5511)
    中文名: 雷多替尼
    Target: PDGFR|Bcr-Abl
    Summary: Bcr-Abl酪氨酸激酶抑制剂
      ≥13.73 mg/mL
      insoluble in H2O
  3. (+)-Apogossypol
    B4902 (+)-Apogossypol
    中文名: 變棉子酚,阿朴棉子酚,变棉子酚
    Target: Bcl-2
    Summary: Bcl-2家族蛋白抑制剂
      ≥16.2 mg/mL
      insoluble in H2O
  4. Regorafenib
    A8236 Regorafenib
     4 Citation
    中文名: 瑞戈非尼
    Target: Raf|VEGFR|PDGFR|c-Kit|RET
    Summary: VEGFR/PDGFR/FGFR/mutant Kit/RET/Raf-1抑制剂
      ≥25.04 mg/mL
      insoluble in H2O
  5. Regorafenib hydrochloride
    A3750 Regorafenib hydrochloride
    中文名: 瑞戈非尼盐酸盐
    Target: Raf|VEGFR|PDGFR|c-Kit|c-RET
    Summary: 酪氨酸激酶抑制剂
      ≥25.95 mg/mL
      insoluble in H2O
  6. Sabutoclax
    A4199 Sabutoclax
     2 Citation
    Target: Bcl-2|Mcl-1|Bfl-1
    Summary: Pan-Bcl-2抑制剂
      ≥205.6 mg/mL
      insoluble in H2O
  7. Apogossypolone (ApoG2)
    A4200 Apogossypolone (ApoG2)
     2 Citation
    Target: Bcl-2|Bcl-xl|Mcl-1
    Summary: Bcl-2的非肽类小分子抑制剂
      ≥24.55 mg/mL
      insoluble in H2O
  8. Obatoclax mesylate (GX15-070)
    A4194 Obatoclax mesylate (GX15-070)
     1 Citation
    中文名: 奥巴克拉甲磺酸盐
    Target: Bcl-2
    Summary: 强效的BCL-2抑制剂
      ≥20.7 mg/mL
      insoluble in H2O
  9. TW-37
    A4234 TW-37
     1 Citation
    Target: Bcl-2|Bcl-xl|Mcl-1
    Summary: Bcl-2抑制剂,抑制Bcl-2、Bcl-XL和Mcl-1。
      ≥19.75 mg/mL
      insoluble in H2O
  10. ABT-263 (Navitoclax)
    A3007 ABT-263 (Navitoclax)
     15 Citation
    Target: Bcl-2|Bcl-w
    Summary: Bcl-2家族抑制剂,可以抑制Bcl-2、 Bcl-xL和Bcl-w。
      ≥48.73 mg/mL
      insoluble in H2O

12件产品中的 1-10

页面
每页